MTOR and prostate cancer: PTX3 interacts with the PI3K/AKT/mTOR signaling pathway or the fibroblast growth factor-2/receptor system to regulate tumor cell proliferation, apoptosis, and metastasis in lung cancer, breast cancer, melanoma, prostate cancer, and multiple myeloma (24, 25).